Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
84 participants
INTERVENTIONAL
2017-08-01
2017-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mechanistic Characterization of Uterine Pain
NCT04145518
Analgesic Efficacy of Repeated Doses of Intravenous (IV) Acetaminophen in Post-operative Pediatric Spine Fusion Patients
NCT01394718
Antipyretics for Preventing Recurrences of Febrile Seizures
NCT00568217
A Multi-Center Study of the Efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of IV Acetaminophen for the Treatment of Acute Pain in Pediatric Patients
NCT01635101
Paracetamol Versus Ibuprofen for PDA Closure
NCT03265782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Non steroidal anti inflammatory Drugs were proved to be one of the alternative medications for spasmodic dysmenorrhea.
Getting the idea of what is called preemptive anesthesia by blocking the receptors before catching pain mediators the study participants will be divided randomly into 2 group group 1 receiving ttt 2 days before the anticipated menstruation and group 2 receiving ttt only during menstruation as analgesia
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
premenstruation group
preemptive mefenamic acid 500mg tablets every 8 hours starting 2 days before anticipated menstruation and during the first 2 days of the cycle
preemptive mefenamic acid
preemptive analgesia before menstrual pain
menstruation group
mefenamic acid 500mg tablets every 8 hours during the first 2 days of the cycle
mefenamic acid
mefenamic acid given only during menstruation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
preemptive mefenamic acid
preemptive analgesia before menstrual pain
mefenamic acid
mefenamic acid given only during menstruation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with regular menstrual cycle pattern
* those experienced history of dysmenorrhea (primary or spasmodic)
* patients able to sallow tables
Exclusion Criteria
* any associated local causes( pelvic infection, endometriosis, fibroid or others)
* patients with familial Mediterranean fever or other intermenstrual attacks of abdominal pain
* gastric or duodenal ulcers or gastritis
* other contraindications to non steroidal anti-inflammatory drugs
* patients with severe diminution of vision or color discrimination
* patients with any depressive or mood disorders
* patients receiving any hormonal treatment
15 Years
25 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hanan Nabil
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hanan Nabil
Associate Professor Obstetrics and Gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hanan Nabil, MD
Role: PRINCIPAL_INVESTIGATOR
Manoura University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University
Al Mansurah, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
27011975
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.